These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 13332176)

  • 1. The pathogenesis of hyperlipemia induced by means of surface-active agents. I. Increased total body cholesterol in mice given triton WR 1339 parenterally.
    HIRSCH RL; KELLNER A
    J Exp Med; 1956 Jul; 104(1):1-13. PubMed ID: 13332176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathogenesis of hyperlipemia induced by means of surface-active agents. II. Failure of exchange of cholesterol between the plasma and the liver in rabbits given triton WR 1339.
    HIRSCH RL; KELLNER A
    J Exp Med; 1956 Jul; 104(1):15-24. PubMed ID: 13332177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triton hyperlipemia in dogs. II. Atheroscieross, diffuse lipidosis, and deletion of fat stores produced by prolonged administration of the non-tonic surface-active agent.
    SCANU A; ORIENTE P; SZAJEWSKI JM; McCORMACK LJ; PAGE IH
    J Exp Med; 1961 Sep; 114(3):279-94. PubMed ID: 13747053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceleration of hepatic cholesterol synthesis by triton WR-1339.
    FRANTZ ID; HINKELMAN BT
    J Exp Med; 1955 Mar; 101(3):225-32. PubMed ID: 13233448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism responsible for the hypercholesteremia induced by triton WR-1339.
    FRIEDMAN M; BYERS SO
    J Exp Med; 1953 Jan; 97(1):117-30. PubMed ID: 13022866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained hyperlipemia induced in rabbits by means of intravenously injected surface-active agents.
    KELLNER A; CORRELL JW; LADD AT
    J Exp Med; 1951 Apr; 93(4):373-84. PubMed ID: 14824409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma protein changes consequent to hyperlipemia induced by cobaltous chloride or Triton WR-1339.
    Zarafonetis CJ; Dabich L; Brody GL
    Am J Med Sci; 1967 Oct; 254(4):506-12. PubMed ID: 6052846
    [No Abstract]   [Full Text] [Related]  

  • 8. The composition of the lipoproteins in the plasma of rabbits with hypercholesterolaemia or triton WR-1339-induced hyperlipaemia.
    GARLICK DG; COURTICE FC
    Q J Exp Physiol Cogn Med Sci; 1962 Jul; 47():211-20. PubMed ID: 13896985
    [No Abstract]   [Full Text] [Related]  

  • 9. THE COMPOSITION OF THE PLASMA LIPOPROTEINS IN EXPERIMENTAL HYPERLIPAEMIA INDUCED BY TRITON WR-1339, CORTISONE, ALLOXAN AND HAEMORRHAGE IN RABBITS.
    COURTICE FC; MUNOZ-MARCUS M
    Q J Exp Physiol Cogn Med Sci; 1964 Oct; 49():430-40. PubMed ID: 14223303
    [No Abstract]   [Full Text] [Related]  

  • 10. Triton hyperlipemia in dogs. I. In vitro effects of the detergent on serum lipoproteins and chylomcrons.
    SCANU A; ORIENTE P
    J Exp Med; 1961 Apr; 113(4):735-57. PubMed ID: 13747054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A procedure for inducing sustained hyperlipemia in rats by administration of a surfactant.
    Levine S; Saltzman A
    J Pharmacol Toxicol Methods; 2007; 55(2):224-6. PubMed ID: 16839786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of triton and diphenylylethylacetic acid on cholesterol and fatty acid biosynthesis in isolated perfused liver.
    GARATTINI S; PAOLETTI P; PAOLETTI R
    Experientia; 1959 Jan; 15(1):33-4. PubMed ID: 13619684
    [No Abstract]   [Full Text] [Related]  

  • 13. Acetate 14C incorporation in hepatic and plasmatic cholesterol during triton-induced hyperlipemia.
    Breillot J; Fourçans B; Melin B; Piot MC; Alcindor LG; Polonovski J
    Steroids Lipids Res; 1974; 5(2):96-100. PubMed ID: 4428494
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of intravenous Triton WR-1339 on factor VII coagulant activity and plasma lipoproteins in normocholesterolaemic and hypercholesterolaemic rabbits.
    Mitropoulos KA; Miller GJ; Howarth DJ; Reeves BE; Cooper JA
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):583-91. PubMed ID: 7841315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. THE FATE OF CHYLOMICRONS IN RATS TREATED WITH TRITON WR-1339.
    Moore WT; Tidwell HC; Mcpherson JC
    Am J Clin Nutr; 1965 Jan; 16():135-40. PubMed ID: 14262109
    [No Abstract]   [Full Text] [Related]  

  • 16. LINOLEIC ACID COMPONENT IN THE HYPERLIPIDEMIA INDUCED BY TRITON.
    IMAI Y; ARAMAKI Y
    Jpn J Pharmacol; 1964 Jun; 14():111-7. PubMed ID: 14215540
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of vincristine of triton WR-1339 induced hyperlipidemia in mice.
    Kremmer T; Holczinger L
    Biochem Pharmacol; 1974 Dec; 23(23):3317-21. PubMed ID: 4441418
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antagonist action of lipoxidase on hyperlipemia induced by Triton WR-1339 in rats].
    Freyss-Beguin M
    C R Seances Soc Biol Fil; 1969 Feb; 162(7):1316-9. PubMed ID: 4238876
    [No Abstract]   [Full Text] [Related]  

  • 19. [Carbohydrate metabolism and endogenous hyperlipemia].
    Voitenko IN
    Ukr Biokhim Zh (1978); 1978; 50(5):618-20. PubMed ID: 726096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vitro effects of Triton WR-1339 on lipid synthesis by bone cells.
    McPherson JC; Schuster GS; Dirksen TR
    Proc Soc Exp Biol Med; 1975 May; 149(1):172-7. PubMed ID: 1144422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.